2009 | Natural polyphenols antagonize the antimyeloma activity of proteasome inhibitor bortezomib by direct chemical interaction | BRITISH JOURNAL OF HAEMATOLOGY |
2006 | Nine-year survival of lymphoblastic lymphoma patients
| YONSEI MEDICAL JOURNAL |
2001 | NK/T 세포 림프종 환자에서 시행된 비골수제거성 조혈모세포이식
| 대한조혈모세포이식학회지 |
2012 | Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients | MEDICAL ONCOLOGY |
2013 | Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study
| RADIATION ONCOLOGY JOURNAL |
2020 | PERK/NRF2 and Autophagy Form a Resistance Mechanism Against G9a Inhibition in Leukemia Stem Cells
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
2022 | Pevonedistat in East Asian patients with acute myeloid leukemia or myelodysplastic syndromes: a phase 1/1b study to evaluate safety, pharmacokinetics and activity as a single agent and in combination with azacitidine
| JOURNAL OF HEMATOLOGY & ONCOLOGY |
2003 | Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome | BRITISH JOURNAL OF HAEMATOLOGY |
2018 | Platelet storage induces accelerated desialylation of platelets and increases hepatic thrombopoietin production
| JOURNAL OF TRANSLATIONAL MEDICINE |
2024 | Poor Mobilization-Associated Factors in Autologous Hematopoietic Stem Cell Harvest
| CANCERS |
2015 | Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation
| BLOOD RESEARCH |
2022 | Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: A Retrospective Study
| CANCER RESEARCH AND TREATMENT |
2016 | Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry.
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2017 | Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma
| ONCOTARGET |
2016 | Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2023 | Primary myelofibrosis-related glomerulopathy with renal extramedullary hematopoiesis | JOURNAL OF NEPHROLOGY |
2016 | Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome
| PLOS ONE |
2017 | Prognostic significance of interventricular septal thickness in patients with AL amyloidosis | LEUKEMIA RESEARCH |
2017 | Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma
| ONCOTARGET |
2007 | Protein kinase CK2α as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia
| CLINICAL CANCER RESEARCH |
2015 | Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience
| RADIATION ONCOLOGY JOURNAL |
2022 | Real-world data on prognostic value of measurable residual disease assessment by fragment analysis or next-generation sequencing in multiple myeloma | BRITISH JOURNAL OF HAEMATOLOGY |
2022 | Results of Multicenter Phase II Study With Imatinib Mesylate in Allogeneic Recipients With Steroid-Refractory Chronic GVHD
| CELL TRANSPLANTATION |
2016 | Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen
| BMC CANCER |
2012 | Risk Factors for Progression from Cytomegalovirus Viremia to Cytomegalovirus Disease after Allogeneic Hematopoietic Stem Cell Transplantation | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
2020 | RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia
| SCIENTIFIC REPORTS |
2014 | Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients | INTERNATIONAL JOURNAL OF HEMATOLOGY |
2022 | Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea
| BLOOD RESEARCH |
2017 | Salvage therapy for acute chemorefractory leukemia by allogeneic stem cell transplantation: the Korean experience | ANNALS OF HEMATOLOGY |
2016 | Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF. | LEUKEMIA & LYMPHOMA |
2020 | Serum albumin and C-reactive protein as significant predictors of non-relapse mortality in lower gastrointestinal graft-versus-host disease | ANNALS OF HEMATOLOGY |
2014 | Serum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromes
| PLOS ONE |
2015 | Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype
| BLOOD CANCER JOURNAL |
2014 | Success Rate and Risk Factors for Failure of Empirical Antifungal Therapy with Itraconazole in Patients with Hematological Malignancies: A Multicenter, Prospective, Open-Label, Observational Study in Korea
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2019 | Targeted next generation sequencing can serve as an alternative to conventional tests in myeloid neopla는
| PLOS ONE |
2017 | Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells. | AUTOPHAGY |
2015 | Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
2022 | The association of genetic alterations with response rate in newly diagnosed chronic myeloid leukemia patients | LEUKEMIA RESEARCH |
2017 | The clonal origins of leukemic progression of myelodysplasia | LEUKEMIA |
2016 | The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase | ANNALS OF HEMATOLOGY |
2014 | The modified Glasgow Prognostic Scores as a predictor in diffuse large B cell lymphoma treated with R-CHOP regimen
| YONSEI MEDICAL JOURNAL |
2017 | The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma | ANNALS OF HEMATOLOGY |
2014 | The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea | ANNALS OF HEMATOLOGY |
2014 | The role of radiotherapy in the management of POEMS syndrome.
| RADIATION ONCOLOGY |
2016 | The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma | BRITISH JOURNAL OF HAEMATOLOGY |
2007 | Therapeutic Comparison of Chemotherapy and Surgery for Early Stage Diffuse Large B-cell Gastric Lymphoma
| YONSEI MEDICAL JOURNAL |
2022 | Therapy-related Acute Lymphoblastic Leukaemia has a Unique Genetic Profile Compared to De Novo Acute Lymphoblastic Leukaemia
| JOURNAL OF CANCER |
2009 | Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia | LEUKEMIA RESEARCH |
2002 | Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype | BRITISH JOURNAL OF HAEMATOLOGY |
2006 | Treatment of Hodgkin's disease: A twenty-year follow-up of patients at a center in Korea
| YONSEI MEDICAL JOURNAL |
2021 | Treatment outcome and prognostic factors of Korean patients with chronic lymphocytic leukemia: a multicenter retrospective study
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2011 | Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia. | LEUKEMIA & LYMPHOMA |
2009 | Two case reports of 1q triplication in myeloproliferative neoplasms. | CANCER GENETICS AND CYTOGENETICS |
2020 | ULK1 Inhibition as a Targeted Therapeutic Strategy for FLT3-ITD-mutated Acute Myeloid Leukemia
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
2021 | Ultra-deep sequencing mutation analysis of the BCR/ABL1 kinase domain in newly diagnosed chronic myeloid leukemia patients | LEUKEMIA RESEARCH |
2024 | Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights
| FRONTIERS IN ONCOLOGY |
2020 | Upfront autologous hematopoietic stem cell transplantation for high-risk patients with double-expressor diffuse large B cell lymphoma | ANNALS OF HEMATOLOGY |
2019 | Use of Droplet Digital Polymerase Chain Reaction for Detecting Minimal Residual Disease: A Prospective Multi-Institutional Study
| IN VIVO |
2023 | Utility of Plasma Microbial Cell-Free DNA Whole-Genome Sequencing for Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancy or COVID-19 | JOURNAL OF INFECTIOUS DISEASES |
2005 | 경구용 steroid나 danazol로 성공적으로 치료된 후천성혈우병 A 2예
| Korean Journal of Hematology |